9th Annual CAR-TCR Summit (U.S.)

Name: 9th Annual CAR-TCR Summit (U.S.)
Start: 2024-09-17
End: 2024-09-20

Navigate the global landscape of autologous and allogeneic cell therapy manufacturing with Syneos Health

Join Syneos Health at the 9th Annual CAR-T Summit to navigate the global landscape of autologous and allogeneic cell therapy manufacturing.

September 17-20, 2024

Book a Meeting

Cell and gene therapy manufacturing holds transformative potential for disease treatment, yet navigating the complexities of autologous and allogeneic cell therapy trials on a global scale presents unique challenges. The journey is often lengthy, costly, and fraught with high failure risks. For biotech firms, especially those operating with finite resources, orchestrating successful cell therapy trials demands strategic planning and expertise. At Syneos Health, we specialize in bridging these gaps for emerging biotech companies.

Meet with Us

Join us at the 9th Annual CAR-T Summit to explore how our collective wisdom and insights can be harnessed to tailor solutions to the specific requirements of your trial. We are committed to ensuring the safety and efficacy of each study, keeping patient welfare at the forefront of our efforts.

Book a Meeting

Clinical Development Chair

Abhi Gupta | Senior Vice President & Head of Cell and Gene Therapy

CAR-TCR Boston Event Chair, Clinical Development Track

Panel Discussion

Unlocking Adoptive Cell Therapy Potential: Proven Strategies for Clinical Success | Wednesday, September 18 at 2:05 PM

Reduce site burden through capabilities that help PIs adjust to new treatment paradigms, operational variations and long-term follow-up safety of patients
Deploy RSLs to overcome hesitancy, communicate scientific and medical requirements, and translate insights into effective patient engagement strategies
De-risk execution of operationally complex trials through medical, scientific and logistical excellence